# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed Apr 29, 2026

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2026-04-29
- Accepted by EDGAR: Apr 29, 2026, 16:05 ET
- Period: 2026-04-28
- Accession: 0000875320-26-000166
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000087532026000166/vrtx-20260428.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000087532026000166/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000087532026000166/vrtx-20260428.htm

Filed Apr 29, 2026.
Source: SEC EDGAR, the filing index for accession 0000875320-26-000166. Last ingested by Listed: Nov 6, 2026, 12:56 ET. No prices; not investment advice.